Chronic obstructive pulmonary disease and cancer risk: A Danish nationwide cohort study

Respiratory Medicine

Volumn 106, Issue 6, 2012, Pages 845-852

  Kornum, Jette Brommann ^a   Sværke, Claus ^a   Thomsen, Reimar Wernich ^a   Lange, Peter ^b   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Chronic obstructive pulmonary disease; Cohort study; Neoplasms; Risk; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PANCREAS CANCER; PHARYNX CANCER; PRIORITY JOURNAL; STOMACH CANCER; TOBACCO; TONGUE CANCER; URINARY TRACT CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; ALCOHOLISM; COMORBIDITY; DENMARK; EPIDEMIOLOGIC METHODS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84859793291     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.12.009     Document Type: Article

References (34)

1. World Health Organization. World health statistics. Geneva: WHO Press; 2008.
2. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121:121S-6S. (Pubitemid 34497328)
3. Hansen JG, Pedersen L, Overvad K, Omland O, Jensen HK, Sorensen HT. The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study. COPD 2008;5:347-52.
4. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. (Pubitemid 47321907)
5. Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010;170:560-5.
6. Fabricius P, Lokke A, Marott JL, Vestbo J, Lange P. Prevalence of COPD in Copenhagen. Respir Med 2011;105:410-7.
7. van der Wal AM, Huizinga E, Orie NG, Sluiter HJ, de VK. Cancer and chronic non-specific lung disease (C.N.S.L.D. Scand J Respir Dis 1966;47:161-72.
8. Rimington J. Smoking, chronic bronchitis, and lung cancer. Br Med J 1971;2:373-5.
9. Legge JS, Palmer KN. Pulmonary function in bronchial carcinoma. Thorax 1973;28:588-91.
10. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey followup. Arch Intern Med 2003;163:1475-80. (Pubitemid 36758921)
11. Koshiol J, Rotunno M, Consonni D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 2009;4:e7380.
12. Purdue MP, Gold L, Jarvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007;62:51-6. (Pubitemid 46101766)
13. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983;128:491-500. (Pubitemid 13006153)
14. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis 1990;141:613-7. (Pubitemid 20109147)
15. van Gestel YR, Hoeks SE, Sin DD, et al. COPD and cancer mortality: the influence of statins. Thorax 2009;64:963-7.
16. Tkac J, Man SF, Sin DD. Systemic consequences of COPD. Ther Adv Respir Dis 2007;1:47-59.
17. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008;31:204-12.
18. Nakayama M, Satoh H, Sekizawa K. Risk of cancers in COPD patients. Chest 2003;123:1775-6.
19. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9.
20. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8. (Pubitemid 29299976)
21. Christensen S, Thomsen RW, Torring ML, Riis A, Norgaard M, Sorensen HT. Impact of COPD on outcome among patients with complicated peptic ulcer. Chest 2008;133:1360-6. (Pubitemid 351892991)
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
23. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997;44:535-9.
24. Sorensen HT, Mellemkjaer L, Skriver MV, et al. Fever of unknown origin and cancer: a population-based study. Lancet Oncol 2005;6:851-5. (Pubitemid 41614796)
25. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC monographs on the evaluation of carcinogenic risks to humans. tobacco smoke and involuntary smoking. Lyon, France: IARCPress AND the World Health Organization Marketing and Dissemination; 2004. Report No. 83.
26. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007;8:292-3.
27. Nasca PC. Immunity and cancer risk. In: Nasca PC, Patides H, editors. Fundamentals of cancer epidemiology. Gaithersburg: Aspen Publishers; 2001. p. 255-73.
28. van de Schans SA, Janssen-Heijnen ML, Biesma B, et al. COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. Eur J Cancer 2007;43:2194-202. (Pubitemid 47539129)
29. Young RP, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD. Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur Respir J 2008;32:1158-64.
30. Thomsen RW, Lange P, Hellquist B, et al. Validity and under-recording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011;3:85-9.
31. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496-9. (Pubitemid 10039553)
32. Agusti A. Systemic effects of COPD: just the tip of the iceberg. COPD 2008;5:205-6.
33. Decramer M, Rennard S, Troosters T, et al. COPDas a lung disease with systemic consequenceseclinical impact, mechanisms, and potential for early intervention. COPD 2008;5:235-56.
34. Lash T, Johansen MB, Christensen S, et al. Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung 2011;189:27-35.